PREGNANCY IN MUSCULAR DYSTROPHIES: A NARRATIVE REVIEW OF CLINICAL RISKS, PHYSICAL ACTIVITY, AND MATERNAL-FETAL OUTCOMES
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6609Keywords:
Pregnancy, Muscular Dystrophies, Muscular Dystrophy, Duchenne, Myotonic Dystrophy, Physical Activity, Exercise, RehabilitationAbstract
Introduction and purpose: Muscular dystrophies are progressive, hereditary muscle disorders whose inheritance pattern and multisystem involvement complicate reproductive decisions, yet evidence on maternal and neonatal outcomes remains fragmented. This review summarises current literature on pregnancy in women with dystrophinopathies, myotonic dystrophy, FSHD, and LGMD, including the role of physical activity and rehabilitation.
Materials and methods: Literature was retrieved from PubMed, Scopus, and Google Scholar (January–June 2025), supplemented by reference list screening, and analysed narratively by subtype.
Review findings: Pregnancy in muscular dystrophy carries elevated but increasingly manageable risk depending on subtype. DM1 is linked to adverse neonatal outcomes via congenital myotonic dystrophy; dystrophinopathy carriers face cardiomyopathy and heart failure risk; FSHD and LGMD show increased instrumental delivery, falls, and weakness, supporting a role for individualised physiotherapy and respiratory training.
Conclusions: Reproductive care in muscular dystrophy benefits from a multidisciplinary approach with cardiac and respiratory monitoring, anaesthetic planning, genetic counselling, and rehabilitation support, though evidence remains limited to case reports and small cohorts.
References
Lovering, R. M., Porter, N. C., & Bloch, R. J. (2005). The muscular dystrophies: From genes to therapies. Phys Ther, 85(12), 1372–1388. Retrieved May 10, 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC4496952/
LaPelusa, A., Asuncion, R. M. D., & Kentris, M. (2026). Muscular dystrophy. In StatPearls. StatPearls Publishing. Retrieved May 20, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK560582/
Crisafulli, S., Sultana, J., Fontana, A., Salvo, F., Messina, S., & Trifirò, G. (2020). Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet J Rare Dis, 15, 141. https://doi.org/10.1186/s13023-020-01430-8
Liao, Q., Zhang, Y., He, J., & Huang, K. (2022). Global prevalence of myotonic dystrophy: An updated systematic review and meta-analysis. Neuroepidemiology, 56(3), 163–173. https://doi.org/10.1159/000524734
Luglio, A., Maggi, E., Riviello, F. N., Conforti, A., Sorrentino, U., & Zuccarello, D. (2024). Hereditary neuromuscular disorders in reproductive medicine. Genes (Basel), 15, 1409. https://doi.org/10.3390/genes15111409
Mercuri, E., Bonnemann, C. G., & Muntoni, F. (2019). Muscular dystrophies. Lancet, 394, 2025–2038. https://doi.org/10.1016/S0140-6736(19)32910-1
Wahlgren, L., Kroksmark, A. K., Tulinius, M., & Sofou, K. (2022). One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure. Eur J Epidemiol, 37(2), 147–156. https://doi.org/10.1007/s10654-021-00819-4
Huzarski, F., Marta, P. K., Ossolińska, A., Ferfecka, G. M., Pawełek, K. A., Stolarska, L., et al. (2025). Respiratory complications and management in Duchenne muscular dystrophy and amyotrophic lateral sclerosis. J Educ Health Sport, 78, 57513. https://doi.org/10.12775/JEHS.2025.78.57513
Bushby, K. M. & Gardner-Medwin, D. (1993). The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. i. natural history. J Neurol, 240(2), 98–104. https://doi.org/10.1007/BF00858725
Zimowski, J. G., Pawelec, M., Purzycka, J. K., et al. (2017). Deletions, not duplications or small mutations, are the predominant new mutations in the dystrophin gene. J Hum Genet, 62, 885–888. https://doi.org/10.1038/jhg.2017.70
Lee, T., Takeshima, Y., Kusunoki, N., et al. (2014). Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients. J Hum Genet, 59, 46–50. https://doi.org/10.1038/jhg.2013.119
Hoogerwaard, E. M., Bakker, E., Ippel, P. F., Oosterwijk, J. C., Majoor-Krakauer, D. F., Leschot, N. J., et al. (1999). Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: A cohort study. Lancet, 353(9170), 2116–2119. https://doi.org/10.1016/S0140-6736(98)10028-4
Glass, I. A., Nicholson, L. V., Watkiss, E., Johnson, M. A., Roberts, R. G., Abbs, S., et al. (1992). Investigation of a female manifesting Becker muscular dystrophy. J Med Genet, 29(8), 578–582. https://doi.org/10.1136/jmg.29.8.578
Adachi, K., Hashiguchi, S., Saito, M., Kashiwagi, S., Miyazaki, T., Kawai, H., et al. (2018). Detection and management of cardiomyopathy in female dystrophinopathy carriers. J Neurol Sci, 386, 74–80. https://doi.org/10.1016/j.jns.2017.12.024
Hori, H., Maeda, Y., Ishizaki, M., et al. (2015). A carrier with de novo mutation in the dystrophin gene whose myopathic symptoms became seriously progressive after pregnancy and delivery. Muscle Nerve, 52(5), 913–914. https://doi.org/10.1002/mus.24744
Schaufelberger, M. (2019). Cardiomyopathy and pregnancy. Heart, 105(20), 1543–1551. https://doi.org/10.1136/heartjnl-2018-313476
Gupta, A., Hazarika, A., Jain, K., Sikka, P., & Suri, V. (2017). An asymptomatic carrier of becker’s muscular dystrophy with cardiomyopathy in pregnancy: Peripartum or not. Int J Obstet Anesth, 30, 77–78. https://doi.org/10.1016/j.ijoa.2016.12.001
Davies, J. E., Winokur, T. S., Aaron, M. F., Benza, R. L., Foley, B. A., & Holman, W. L. (2001). Cardiomyopathy in a carrier of duchenne’s muscular dystrophy. J Heart Lung Transplant, 20(7), 781–784. https://doi.org/10.1016/s1053-2498(00)00240-0
Cheng, V. E. & Prior, D. L. (2013). Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy. Heart Lung Circ, 22(8), 677–681. https://doi.org/10.1016/j.hlc.2012.11.015
Kinugawa, M., Ichinose, M., Matsui, H., Xiang, Z., Sayama, S., Toshimitsu, M., et al. (2025). Successful pregnancy outcome with preconception care in a symptomatic carrier of Duchenne muscular dystrophy: Case report and literature review. Am J Med Genet A, 197, e63926. https://doi.org/10.1002/ajmg.a.63926
Lamanna, B., Vinciguerra, M., Dellino, M., Cascella, G., Cazzato, G., Macorano, E., et al. (2022). Turner syndrome mosaicism 45,X/46,XY with genital ambiguity and Duchenne muscular dystrophy: Translational approach of a rare Italian case. Int J Mol Sci, 23, 14408. https://doi.org/10.3390/ijms232214408
Fratter, C., Dalgleish, R., Allen, S. K., et al. (2020). EMQN best practice guidelines for genetic testing in dystrophinopathies. Eur J Hum Genet, 28, 1141–1159. https://doi.org/10.1038/s41431-020-0643-7
Superson, M., Szmyt, K., Wilk-Trytko, K., Krasnoborska, J., Samojedny, S., Szymańska, K., et al. (2024). Applications of gene modification technologies in the treatment of inherited diseases. J Educ Health Sport, 66, 50073. https://doi.org/10.12775/JEHS.2024.66.002
Ali, A., Rahman, M. Y., & Sheikh, D. (2024). The role of CRISPR/Cas9 in revolutionizing duchenne's muscular dystrophy treatment: Opportunities and obstacles. Glob Med Genet, 11(4), 349–357. https://doi.org/10.1055/s-0044-1791803
Michalska, A. T., Świda, M., Kubuj, C., Adaśko, G., Mazur, U., Bazarewicz, J., Siwik, M., Dmowski, D., Ogonowska, P., & Waszak, J. (2025). Duchenne muscular dystrophy - disease characterization and emergent genetic therapy - literature review. Quality in Sport, 43, 62338. https://doi.org/10.12775/QS.2025.43.62338
Thornton, C. A. (2014). Myotonic dystrophy. Neurol Clin, 32(3), 705–719. https://doi.org/10.1016/j.ncl.2014.04.011
Ranum, L. P., Rasmussen, P. F., Benzow, K. A., Koob, M. D., & Day, J. W. (1998). Genetic mapping of a second myotonic dystrophy locus. Nat Genet, 19(2), 196–198. https://doi.org/10.1038/570
Ashizawa, T., Gagnon, C., Groh, W. J., et al. (2018). Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract, 8(6), 507–520. https://doi.org/10.1212/CPJ.0000000000000531
Schoser, B., Montagnese, F., Bassez, G., et al. (2019). Consensus-based care recommendations for adults with myotonic dystrophy type 2. Neurol Clin Pract, 9(4), 343–353. https://doi.org/10.1212/CPJ.0000000000000645
Vydra, D. G. & Rayi, A. (2026). Myotonic dystrophy. In StatPearls. StatPearls Publishing. Retrieved June 2, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK557446/
Turner, C. & Hilton-Jones, D. (2010). The myotonic dystrophies: Diagnosis and management. J Neurol Neurosurg Psychiatry, 81(4), 358–367. https://doi.org/10.1136/jnnp.2008.158261
Lanni, S. & Pearson, C. E. (2019). Molecular genetics of congenital myotonic dystrophy. Neurobiol Dis, 132, 104533. https://doi.org/10.1016/j.nbd.2019.104533
Jain, A. & Al Khalili, Y. (2026). Congenital myotonic dystrophy. [updated 2023 feb 2]. In StatPearls. StatPearls Publishing. Retrieved April 15, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK560518/
Johnson, N. E., Aldana, E. Z., Angeard, N., Ashizawa, T., Berggren, K. N., et al. (2019). Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1. Neurol Clin Pract, 9(5), 443–454. https://doi.org/10.1212/CPJ.0000000000000646
Johnson, N. E., Hung, M., Nasser, E., Hagerman, K. A., Chen, W., Ciafaloni, E., et al. (2015). The impact of pregnancy on myotonic dystrophy: A registry-based study. J Neuromuscul Dis, 2(4), 447–452. https://doi.org/10.3233/JND-150095
Rudnik-Schöneborn, S. & Zerres, K. (2004). Outcome in pregnancies complicated by myotonic dystrophy: A study of 31 patients and review of the literature. Eur J Obstet Gynecol Reprod Biol, 114(1), 44–53. https://doi.org/10.1016/j.ejogrb.2003.11.025
Rudnik-Schöneborn, S., Schneider-Gold, C., Raabe, U., Kress, W., Zerres, K., & Schoser, B. G. (2006). Outcome and effect of pregnancy in myotonic dystrophy type 2. Neurology, 66(4), 579–580. https://doi.org/10.1212/01.wnl.0000198227.91131.1e
Zagorda, B., Camdessanché, J. P., & Féasson, L. (2021). Pregnancy and myopathies: Reciprocal impacts between pregnancy, delivery, and myopathies and their treatments: A clinical review. Rev Neurol (Paris), 177(3), 225–234. https://doi.org/10.1016/j.neurol.2020.09.014
Statland, J. M. & Tawil, R. (2016). Facioscapulohumeral muscular dystrophy. Continuum (Minneap Minn), 22(6), 1916–1931. https://doi.org/10.1212/CON.0000000000000399
Statland, J. & Tawil, R. (2014). Facioscapulohumeral muscular dystrophy. Neurol Clin, 32(3), 721–728. https://doi.org/10.1016/j.ncl.2014.04.003
Tawil, R. & van der Maarel, S. M. (2006). Facioscapulohumeral muscular dystrophy. Muscle Nerve, 34(1), 1–15. https://doi.org/10.1002/mus.20522
Vincenten, S. C. C., van der Stoep, N., Paulussen, A. D. C., Mul, K., Badrising, U. A., Kriek, M., et al. (2022). Facioscapulohumeral muscular dystrophy: Reproductive counseling, pregnancy, and delivery in a complex multigenetic disease. Clin Genet, 101, 149–160. https://doi.org/10.1111/cge.14031
McNiff, M. M., Hawkins, S., Haase, B., Bullivant, J., McIver, T., Mitelman, O., Emery, N., Tasca, G., Voermans, N., & Diaz-Manera, J. (2024). Facioscapulohumeral muscular dystrophy European patient survey: Assessing patient reported disease burden and preferences in clinical trial participation. J Neuromuscul Dis, 11(2), 459–472. https://doi.org/10.3233/JND-230171
Ciafaloni, E., Pressman, E. K., Loi, A. M., Smirnow, A. M., Guntrum, D. J., Dilek, N., et al. (2006). Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology, 67, 1887–1889. https://doi.org/10.1212/01.wnl.0000244471.05316.19
Rudnik-Schöneborn, S., Glauner, B., Röhrig, D., & Zerres, K. (1997). Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch Neurol, 54(7), 888–94. https://doi.org/10.1001/archneur.1997.00550190076017
Gatica, L. V. & Rosa, A. L. (2016). A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy. Neuromuscul Disord, 26(12), 844–852. https://doi.org/10.1016/j.nmd.2016.09.015
Giardina, E., Camaño, P., Burton-Jones, S., Ravenscroft, G., Henning, F., Magdinier, F., et al. (2024). Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines. Clin Genet, 106(1), 13–26. https://doi.org/10.1111/cge.14533
Straub, V., Murphy, A., & Udd, B. (2018). 229th ENMC international workshop: Limb girdle muscular dystrophies—nomenclature and reformed classification, naarden, the Netherlands, 17-19 march 2017. Neuromuscul Disord, 28(8), 702–710. https://doi.org/10.1016/j.nmd.2018.05.007
Johnson, N. E. & Statland, J. M. (2022). The Limb-Girdle muscular dystrophies. Continuum (Minneap Minn), 28(6), 1698–1714. https://doi.org/10.1212/CON.0000000000001178
Moore, U., Emmons, S. S., Rufibach, L., Straub, V., Diaz-Manera, J., & Guglieri, M. (2023). Patient reported pregnancy and birth outcomes in genetic neuromuscular diseases. Neuromuscul Disord, 33, 241–249. https://doi.org/10.1016/j.nmd.2022.12.013
von Guionneau, A., Burford, C., & Stone, S. (2019). Obstetric management of a woman with limb-girdle muscular dystrophy type 2i and dilated cardiomyopathy. Obstet Med, 12(4), 199–201. https://doi.org/10.1177/1753495X18814622
Libell, E. M., Bowdler, N. C., Stephan, C. M., Zimmerman, M. B., Gedlinske, A. M., & Mathews, K. D. (2021). The outcomes and experience of pregnancy in limb girdle muscular dystrophy type R9. Muscle Nerve, 63(6), 812–817. https://doi.org/10.1002/mus.27184
Mathur, P., Kaur, A., Vijay, U., Gupta, A., Agarwal, K., & Agrawal, L. (2024). Limb-girdle muscular dystrophies (LGMD): Clinical features, diagnosis and genetic variability through next generation sequencing. Glob Med Genet, 12(1), 100035. https://doi.org/10.1016/j.gmg.2024.100035
Mazzoni, A., Althabe, F., Liu, N. H., Bonotti, A. M., Gibbons, L., Sánchez, A. J., et al. (2011). Women’s preference for caesarean section: A systematic review and meta-analysis of observational studies. BJOG, 118(4), 391–399. https://doi.org/10.1111/j.1471-0528.2010.02793.x
Tefera, M., Jemberu, L., Getachew, E., Andarge, G. A., Seid, K., Lakew, G., et al. (2025). Global preferences and determinant variables of caesarean delivery among pregnant women: A systematic review and meta-analysis. Sultan Qaboos Univ Med J, 25, 1166–1175. https://doi.org/10.18295/2075-0528.2948
Krysińska, A., Drzewiecka, A., Drzewiecki, A., Korczak, W., Gaszyńska, M., Madejska, M. A., Rudzka, A., Falkowski, W., Woźniak, W., & Magielski, J. (2025). The role of physical activity during pregnancy and its impact on the course of labour and labor outcomes - a review of literature. Quality in Sport, 41, 59997. https://doi.org/10.12775/QS.2025.41.59997
Sadowski, J., Dołęga, J., Zabawa, B., Łabuś, M., Krzykawski, K., Papież, Ł., Maciejczyk, T., Sieńko, A., Hudzińska, P., & Mól, P. (2024). Physical activity in pregnancy: A preventive measure against postpartum depression. Quality in Sport, 36, 56364. https://doi.org/10.12775/QS.2024.36.56364
Chawrylak, K., Kubas, M., Krzemińska, K., Kuszneruk, J., & Kłusek, M. (2024). Physical activity during postpartum period - an analysis of the latest studies and guidelines. Quality in Sport, 18, 53253. https://doi.org/10.12775/QS.2024.18.53253
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Maria Całusińska-Skowron, Klaudia Jeziorowska, Anna Kudłacik, Oktawian Kaczmarek, Karolina Bałdys , Magdalena Franków, Kornel Adrian Jarosz, Aleksandra Karolina Schmidt, Aleksandra Regina Żmuda, Julia Łukasik
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
